Literature DB >> 12871175

The immunocompromised host: immune alterations in splenectomized patients and clinical implications.

E Jirillo1, M L Mastronardi, M Altamura, I Munno, S Miniello, G Urgesi, L Amati.   

Abstract

The spleen plays a paramount role in the host protection against invading microorganisms. In support of the above concept, in splenectomized patients there is increasing evidence of overwhelming postsplenectomy infections (OPSI). OPSI are caused by Streptococcus pneumoniae in about 80% of cases, but also Gram-negative bacteria are implicated in a certain number of cases. Therapeutically, penicillin and pneumococcal vaccines represent valid therapeutic approaches in Gram-positive OPSI. However, the effectiveness of polyvalent polysaccharide pneumococcal vaccines is still debated and, thus, other therapeutic strategies should be validated for combating OPSI. According to our personal data, a deficit of phagocytic activities and of T helper (h)-1 cells is very frequent in splenectomized patients. In sera, we found reduced levels of both Interferon-gamma and Interleukin (IL)-4. These data are in accordance with the recent observation on the protective role of T cells against S. pneumoniae. In fact, patients deficient in IL-12 develop severe pneumococcal infections and undergo apoptosis of Th(1) cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871175     DOI: 10.2174/1381612033454306

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1.

Authors:  Asada Leelahavanichkul; Yuning Huang; Xuzhen Hu; Hua Zhou; Takayuki Tsuji; Richard Chen; Jeffrey B Kopp; Jürgen Schnermann; Peter S T Yuen; Robert A Star
Journal:  Kidney Int       Date:  2011-08-10       Impact factor: 10.612

2.  Anti-Pneumococcal Vaccine-Induced Cellular Immune Responses in Post-Traumatic Splenectomized Individuals.

Authors:  Djursun Karasartova; Umut Gazi; Ozgur Tosun; Ayse S Gureser; Ibrahim T Sahiner; Mete Dolapci; Aysegul T Ozkan
Journal:  J Clin Immunol       Date:  2017-05-09       Impact factor: 8.317

3.  Atypical dengue Fever in a splenectomized boy with glucose-6- phosphodehydrogenase deficiency and thalassemia intermedia.

Authors:  Veronique Dinand; Vera Metzler; Satya Prakash Yadav; Anupam Sachdeva
Journal:  Indian J Pediatr       Date:  2010-12-17       Impact factor: 1.967

4.  Prevention of overwhelming postsplenectomy infection in thalassemia patients by partial rather than total splenectomy.

Authors:  Anwar K Sheikha; Ziyan T Salih; Kalandar H Kasnazan; Mohammad K Khoshnaw; Talal Al-Maliki; Tarek A Al-Azraqi; Mubarak H Zafer
Journal:  Can J Surg       Date:  2007-10       Impact factor: 2.089

5.  Overtightening of halo pins resulting in intracranial penetration, pneumocephalus, and epileptic seizure.

Authors:  Alexander W Glover; Rasheed Zakaria; Paul May; Chris Barrett
Journal:  Int J Spine Surg       Date:  2013-12-01

6.  Splenectomy Correlates With Increased Risk of Acute Pancreatitis: A Case-Control Study in Taiwan.

Authors:  Shih-Wei Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  J Epidemiol       Date:  2016-04-16       Impact factor: 3.211

7.  Population-based cohort study examining the association between splenectomy and empyema in adults in Taiwan.

Authors:  Hsien-Feng Lin; Kuan-Fu Liao; Ching-Mei Chang; Cheng-Li Lin; Shih-Wei Lai
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

8.  Gastrectomy correlates with increased risk of pulmonary tuberculosis: A population-based cohort study in Taiwan.

Authors:  Kao-Chi Cheng; Kuan-Fu Liao; Cheng-Li Lin; Shih-Wei Lai
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

9.  Splenectomy Correlates With Increased Risk of Pyogenic Liver Abscess: A Nationwide Cohort Study in Taiwan.

Authors:  Shih-Wei Lai; Hsueh-Chou Lai; Cheng-Li Lin; Kuan-Fu Liao
Journal:  J Epidemiol       Date:  2015-08-08       Impact factor: 3.211

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.